Close

Expertise

Therapeutic Expertise

Trusted by industry leaders for our experience, Med Communications has expertise in over 90 therapeutic areas, including cardiovascular, gastrointestinal, pulmonary, and biologics. We have further specialization in support of vaccines, rare disease/ orphan drugs, and oncology.

  • Oncology

    • Immuno-Oncology
    • Breast Cancer
    • Colon Cancer
    • Renal Cell Carcinoma
    • Melanoma
    • Head and Neck Cancers
    • Prostate Cancer
    • Myeloproliferative Neoplasms
  • Infectious Disease

    • Influenza
    • Vaccines
    • HIV
    • Antibacterials
    • CMV
    • RSV
  • Women's Health

    • Oral Contraceptives
    • Hormonal Replacement Therapy
    • Emergency Contraceptive
    • Fertility/Infertility
  • Cardiovascular

    • Hypertension
    • Acute Coronary Syndromes
    • Arrhythmias
    • Ischemia
    • Angina
    • Hypercholesterolemia
  • Gastrointestinal

    • H. Plyori
    • GERD
    • Hypersecretory Conditions
    • Ulcerative Colitis
  • Pulmonary

    • Asthma
    • COPD
    • Cystic Fibrosis
    • Pneumonia
    • Allergic Rhinitis
    • Pulmonary Arterial Hypertension
  • Neurology/CNS

    • Epilepsy
    • Multiple Sclerosis
    • Acute and Chronic Pain
    • ADHD
    • Antipsychotics
  • Biologics

    • Crohns Disease
    • Plaque Psoriasis
    • Psoriatic Arthritis
  • Renal

    • Chronic Renal Disease
    • End Stage Renal Disease
  • Rare Disease / Orphan Drugs

    • Cystic fibrosis
    • Alpha-1 antitrypsin deficiency, CAPS, PNH, VOD, and lysosomal storage disorders
    • Myelofibrosis and polycythemia
    • Medullary thyroid cancer, generalized lipodystrophy, and familial chylomicronemia syndrome
    • Hemophilia A and B
    • Biallelic RPE65 mutation
  • Other

    • Medical Devices
    • Orphan Drugs
    • Growth Hormone Deficiency

Oncology

  • Immuno-Oncology
  • Breast Cancer
  • Colon Cancer
  • Renal Cell Carcinoma
  • Melanoma
  • Head and Neck Cancers
  • Prostate Cancer
  • Myeloproliferative Neoplasms

Infectious Disease

  • Influenza
  • Vaccines
  • HIV
  • Antibacterials
  • CMV
  • RSV

Women's Health

  • Oral Contraceptives
  • Hormonal Replacement Therapy
  • Emergency Contraceptive
  • Fertility/Infertility

Cardiovascular

  • Hypertension
  • Acute Coronary Syndromes
  • Arrhythmias
  • Ischemia
  • Angina
  • Hypercholesterolemia

Gastrointestinal

  • H. Plyori
  • GERD
  • Hypersecretory Conditions
  • Ulcerative Colitis

Pulmonary

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Pneumonia
  • Allergic Rhinitis
  • Pulmonary Arterial Hypertension

Neurology/CNS

  • Epilepsy
  • Multiple Sclerosis
  • Acute and Chronic Pain
  • ADHD
  • Antipsychotics

Biologics

  • Crohns Disease
  • Plaque Psoriasis
  • Psoriatic Arthritis

Renal

  • Chronic Renal Disease
  • End Stage Renal Disease

Rare Disease / Orphan Drugs

  • Cystic fibrosis
  • Alpha-1 antitrypsin deficiency, CAPS, PNH, VOD, and lysosomal storage disorders
  • Myelofibrosis and polycythemia
  • Medullary thyroid cancer, generalized lipodystrophy, and familial chylomicronemia syndrome
  • Hemophilia A and B
  • Biallelic RPE65 mutation

Other

  • Medical Devices
  • Orphan Drugs
  • Growth Hormone Deficiency

Launch Experience

The teams at Med Communications know all the necessary elements needed during all phases of the product life cycle. On a daily basis, Med Communications assists and advises its clients to ensure successful product launches. With hundreds of product launches successfully implemented, we are ready to support you during your launch journey!

Vaccine Information Experts

Med Communications is extremely strong in its vaccine support portfolio. Med Communications supports 60% of the United States’ influenza manufacturers, and one-third of total influenza products on the market. During the 2009 H1N1 pandemic, Med Communications managed an increase of call volume greater than 1000% and our service levels never dipped under 90% of key performance indicators (KPIs). We are extremely proficient in seasonal products and also support respiratory syncytial virus (RSV), travel vaccines, and childhood immunizations.

Rare Disease/Orphan Drugs

Our trained healthcare providers specialize in the highly complex areas of rare disease/orphan drugs and oncology, and they are ready to hit the ground running in support of your product needs. We guide our rare disease and oncology partners in all aspects of medical affairs, including launch consulting, medical information call center, medical writing, and pharmacovigilance.

Therapeutic Expertise

Trusted by industry leaders for our experience, Med Communications has expertise in over 90 therapeutic areas, including cardiovascular, gastrointestinal, pulmonary, and biologics. We have further specialization in support of vaccines, rare disease/ orphan drugs, and oncology.

  • Oncology

    • Immuno-Oncology
    • Breast Cancer
    • Colon Cancer
    • Renal Cell Carcinoma
    • Melanoma
    • Head and Neck Cancers
    • Prostate Cancer
    • Myeloproliferative Neoplasms
  • Infectious Disease

    • Influenza
    • Vaccines
    • HIV
    • Antibacterials
    • CMV
    • RSV
  • Women’s Health

    • Oral Contraceptives
    • Hormonal Replacement Therapy
    • Emergency Contraceptive
    • Fertility/Infertility
  • Cardiovascular

    • Hypertension
    • Acute Coronary Syndromes
    • Arrhythmias
    • Ischemia
    • Angina
    • Hypercholesterolemia
  • Gastrointestinal

    • H. Plyori
    • GERD
    • Hypersecretory Conditions
    • Ulcerative Colitis
  • Pulmonary

    • Asthma
    • COPD
    • Cystic Fibrosis
    • Pneumonia
    • Allergic Rhinitis
    • Pulmonary Arterial Hypertension
  • Neurology/CNS

    • Epilepsy
    • Multiple Sclerosis
    • Acute and Chronic Pain
    • ADHD
    • Antipsychotics
  • Biologics

    • Crohns Disease
    • Plaque Psoriasis
    • Psoriatic Arthritis
  • Renal

    • Chronic Renal Disease
    • End Stage Renal Disease
  • Rare Disease / Orphan Drugs

    • Cystic fibrosis
    • Alpha-1 antitrypsin deficiency, CAPS, PNH, VOD, and lysosomal storage disorders
    • Myelofibrosis and polycythemia
    • Medullary thyroid cancer, generalized lipodystrophy, and familial chylomicronemia syndrome
    • Hemophilia A and B
    • Biallelic RPE65 mutation

Oncology

  • Immuno-Oncology
  • Breast Cancer
  • Colon Cancer
  • Renal Cell Carcinoma
  • Melanoma
  • Head and Neck Cancers
  • Prostate Cancer
  • Myeloproliferative Neoplasms

Infectious Disease

  • Influenza
  • Vaccines
  • HIV
  • Antibacterials
  • CMV
  • RSV

Women’s Health

  • Oral Contraceptives
  • Hormonal Replacement Therapy
  • Emergency Contraceptive
  • Fertility/Infertility

Cardiovascular

  • Hypertension
  • Acute Coronary Syndromes
  • Arrhythmias
  • Ischemia
  • Angina
  • Hypercholesterolemia

Gastrointestinal

  • H. Plyori
  • GERD
  • Hypersecretory Conditions
  • Ulcerative Colitis

Pulmonary

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Pneumonia
  • Allergic Rhinitis
  • Pulmonary Arterial Hypertension

Neurology/CNS

  • Epilepsy
  • Multiple Sclerosis
  • Acute and Chronic Pain
  • ADHD
  • Antipsychotics

Biologics

  • Crohns Disease
  • Plaque Psoriasis
  • Psoriatic Arthritis

Renal

  • Chronic Renal Disease
  • End Stage Renal Disease

Rare Disease / Orphan Drugs

  • Cystic fibrosis
  • Alpha-1 antitrypsin deficiency, CAPS, PNH, VOD, and lysosomal storage disorders
  • Myelofibrosis and polycythemia
  • Medullary thyroid cancer, generalized lipodystrophy, and familial chylomicronemia syndrome
  • Hemophilia A and B
  • Biallelic RPE65 mutation